secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2025-02-07T23:59:59+00:00
Accession:  0000950170-25-016378
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya appoints interim PAO and reprices CEO underwater options to $1.21
------------------------------------------------------------------------

- Tomohiro Higa appointed Interim Principal Accounting Officer effective Feb 6, 2025; he remains SVP Finance.
- Board repriced CEO Faraz Ali's underwater options: new exercise price $1.21 per share on 915,875 shares.
- Prior exercise prices ranged from $5.64 to $15.19; repricing contingent on retention through July 24, 2025.
- If CEO exercises before retention date, he must pay the original higher exercise price.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000095017025016378/0000950170-25-016378-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000095017025016378/tnya-20250206.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-016378

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer